United States · Series C startup

Who invested in Scorpion Therapeutics

One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$150Mraised across 1 round since 2024, from 1 source

Latest round
Series C, $150MJul 2024
Investors
5
See who backed them

The rounds

  1. Jul 2024
    Series C$150M

    Source recordedSEC filing: $126M sold, first sale Jul 2024

Everyone who backed them

OrbiMedPrivate equity1round
Janus Henderson InvestorsPrivate equity1round
Omega FundsVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Scorpion Therapeutics

Who invested in Scorpion Therapeutics?

Scorpion Therapeutics's investors include Lightspeed Venture Partners, OrbiMed, Wellington Management, Janus Henderson Investors and Omega Funds.

How much has Scorpion Therapeutics raised?

Scorpion Therapeutics has raised $150M across 1 round since 2024.

When did Scorpion Therapeutics last raise?

Scorpion Therapeutics's most recent round was a Series C of $150M in Jul 2024.

What was Scorpion Therapeutics's biggest round?

Its most recent round, $150M in Jul 2024, is also its largest on record.

Who backed Scorpion Therapeutics first?

Scorpion Therapeutics's first round on record, in Jul 2024, was backed by Lightspeed Venture Partners, OrbiMed and Wellington Management and 2 others.

What stage is Scorpion Therapeutics at?

Scorpion Therapeutics's latest named round is a Series C, in Jul 2024.

Where is Scorpion Therapeutics based?

Scorpion Therapeutics is based in the United States.

Companies like Scorpion Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.